Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.
2 other identifiers
interventional
102
1 country
1
Brief Summary
The purpose of this study is to find out how meditation influences certain systems in the body: nervous system, hormonal system, and respiratory system. Another purpose is to see how meditation may help improve post-traumatic stress disorder symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2008
CompletedFirst Posted
Study publicly available on registry
October 24, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJuly 13, 2015
July 1, 2015
5.3 years
October 22, 2008
July 9, 2015
Conditions
Outcome Measures
Primary Outcomes (3)
Attentional Network Task: conflict effect score
Change from Baseline to Endpoint visit (one week after last training visit)
Awakening cortisol values
Change from Baseline to Endpoint visit (one week after last training visit)
Post-traumatic stress disorder checklist-hyperarousal score
Change from Baseline to Endpoint visit (one week after last training visit)
Secondary Outcomes (3)
Intrusive Thought Scale
Change from Baseline to Endpoint visit (one week after last training visit)
EEG event-related negativity during Attentional Network Task
Change from Baseline to Endpoint visit (one week after last training visit)
Heart rate
Change from Baseline to Endpoint visit (one week after last training visit)
Study Arms (4)
Slow Breathing Group
EXPERIMENTALMeditation Group
EXPERIMENTALMeditation and Slow Breathing Group
EXPERIMENTALSitting Quietly Group
PLACEBO COMPARATORInterventions
The slowed breathing group will be trained on a breathing device, RESPeRATE, designed to reduce respiratory rate.They will practice with RESPeRATE once a week (for 6 weeks) in the laboratory with the research staff.
The Mindfulness Body Scan meditation will be used for the mindfulness meditation group.Participants will be trained once a week (for six weeks) in the laboratory by the research staff.
A structured Mindfulness breathing will be guided by the research staff during the lab trainings. The participant will sit upright and attempt to focus attention on his or her own breath as it passes the opening of the nostrils or on the rising and falling of the abdomen or chest. Whenever attention wanders from the breath, the participant will simply notice the distracting thought and then let it go as attention is returned to the breath. Training will be given once every week for 6 weeks.
The SQ control group's "intervention" will include sitting quietly and listening to a neutral-content book on tape to serve as a time and attention control at each laboratory session. They will also be asked to sit quietly at home daily.
Eligibility Criteria
You may qualify if:
- Combat veteran (defined by a score of ≥7 on the Combat exposure scale)
- Chronic PTSD diagnosis
- Age range (25-65 years)
- Both genders
- Good general medical health
- Stable dose of medications for concurrent stable medical conditions for at least 4 weeks prior to start of the study.
- Willing and able to provide informed consent.
You may not qualify if:
- Significant chronic medical illness including:
- current cancer treatment,
- unstable angina,
- recent myocardial infarction,
- current or past history of stroke,
- transient ischemic attack,
- congestive heart failure,
- chronic renal or hepatic failure,
- hypothyroidism
- Psychiatric or behavioral illness including:
- schizophrenia,
- schizoaffective disorder,
- bipolar disorder,
- psychotic disorder (not including transient dissociative states or flashbacks associated with PTSD re-experiencing symptoms),
- any DSM-IV cognitive disorder,
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health and Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helane Wahbeh, ND
Oregon Health and Science University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 22, 2008
First Posted
October 24, 2008
Study Start
January 1, 2009
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
July 13, 2015
Record last verified: 2015-07